This year, PMFG21 is a three-day event with post-conference satellite meeting, centered around four themes:
**TRACKS 1 & 2 and 3 & 4 WILL RUN IN CONCURRENT SESSIONS
Day 1: Saturday 4th December 2021 - TRACK 1 | |||
“FUTURE OF PEDIATRIC GENOMIC MEDICINE” | |||
14:00 | 14:10 | Opening Remarks Dr. Khalid Fakhro- Chief Research Officer Dr. Ammira Akil – Organizing Chair of Track 1 Dr. Younes Mokrab – Organizing Chair of Track 2 Sidra Medicine, Qatar |
|
Session 1: Genomic landscape in complex pediatric disorders and its impact on research and medicine | |||
Objectives:
|
|||
14: 10 | 14: 40 | Opening Keynote Speaker: Dr. Hakon Hakonarson Children’s Hospital of Philadelphia, USA |
Precision Medicine Approaches in the Diagnosis and Treatment of Complex Pediatric Disorders |
14: 40 | 15: 00 | Session Keynote: Dr. Adam Jaffe University of New South Wales, UK |
Precision Medicine in Cystic Fibrosis” |
15: 00 | 15: 20 | Dr. Theodore Laetsch Children's Hospital of Philadelphia, USA |
Molecular targeted therapies for children with difficult to be treated cancers |
15:20 | 15:40 | Dr. Amal Hassan Sidra Medicine, Qatar | Precision Medicine in Disorders of Immune Dysregulation |
15: 40 | 16: 00 | Dr. Struan F.A. Grant Children's Hospital of Philadelphia, USA |
Precision medicine role in metabolic disorders, diabetes, and obesity |
16: 00 | 16: 15 | Break | |
Session 2: Precision Medicine in Pediatric Disorders: Opportunities for Improved Patient Care | |||
Objectives:
|
|||
16:15 | 16:35 | Session keynote Speaker: Dr. Stephen Scherer The Hospital for Sick Children, University of Toronto, Canada |
Precision Medicine Landscape in Canada |
16:35 | 16:55 | Dr. Ma’n Zawati McGill University, Canada |
TBC |
16:55 | 17:15 | Dr. Mustafa Khokha Yale School of Medicine, USA |
Precision Medicine Role in Critical Illness in Infants and Children |
17:15 | 17:35 | Dr. Christian P. Schaaf University of Heidelberg |
Genetic causes of neurodevelopmental and neuropsychiatric disorders |
17:35 | 17:50 | Break | |
Session 3: Integration of personalized medicine into complex diseases prevention | |||
Objectives:
|
|||
17:50 | 18:10 | Session keynote Speaker: Dr. C Thomas Caskey Baylor College of Medicine, USA |
“Precision medicine for disease prevention" |
18:10 | 18:30 | Dr. Carmella Evans Molina Indiana University |
Precision approaches to disease modifying therapy in type 1 diabetes |
18:30 | 18:50 | Dr. Richard Oram Exeter University, UK |
The role of genetic screening in type 1 diabetes prediction |
18:50 | 19:20 | Closing Keynote Speaker: Dr. Robert Green Harvard Medical School, USA |
“Newborn Sequencing with its Implications for lifelong Precision Care” |
19:20 | 19:25 | Closing Remarks by Dr. Ammira Akil |
Day 1: Saturday 4th December 2021 - TRACK 2 | |||
“LARGE SCALE GENOMES AND DATA: FROM DISCOVERY TO HEALTH” | |||
14:00 | 14:10 | Welcome Note Dr. Younes Mokrab Sidra Medicine, Qatar |
|
Session 1: Data Resources Enabling Genomic Medicine | |||
Objectives:
|
|||
14:10 | 14:40 | Keynote Speaker: Dr. John Mattick University of New South Wales Sydney, Australia |
Transforming healthcare with genomic information |
14:40 | 15:00 | Dr. Dave Brown Qatar Precision Medicine Institute, Qatar |
Federation of case reference data is vital for precision medicine |
15:00 | 15:20 | Dr. Ingrid Sheffer University of Melbourne, Australia |
“Precision Medicine n Epilepsy” |
15:20 | 15:40 | Dr. Joel Dudley Mount Sinai, USA |
“Large Scale Genomics Studies in Understudied Populations” |
15:40 | 16:00 | Dr. Michelle Trenkmann Springer Nature, UK |
The role of journals in supporting translational research in understudied populations |
16:00 | 16:15 | Break | |
Session 2: Impact of Large Sequencing Consortia | |||
Objectives:
|
|||
16:15 | 16:35 | Dr. Said Ismail Qatar Genome Program, Qatar |
Qatar Genome; Spearheading Qatar’s Precision Medicine Agenda |
16:35 | 16:55 | Dr. Fowzan AlKuraya King Faisal Specialist Hospital and Research Centre, KSA |
Large scale Mendelian genomics programs as enablers of precision medicine |
16:55 | 17:15 | Dr. Christopher Mason Weill Cornell Medicine NY, USA |
Global and space station mapping of emerging viruses |
17:15 | 17:35 | Dr. Michele Ceccarelli University of Naples Federico II, Italy |
Large scale computational systems biology in cancer genomics |
17:35 | 17:50 | Break | |
Session 3: Actionable Genome and Phenome | |||
Objectives:
|
|||
17:50 | 18:10 | Dr. Laura Addis GSK, UK |
Recall-by-genotype studies in genetics-driven drug discovery |
18:10 | 18:30 | Dr. Rafael Rosengarten Genialis, USA |
A Million to One: Bridging the Biomarker Chasm from Discovery to the Clinic |
18:30 | 18:50 | Dr. Habiba Alsafar Khalifa University, UAE |
Making medicine personal in the Middle East |
18:50 | 19:20 | Keynote Speaker: Dr. Nancy Cox Vanderbilt University, USA |
Integration of Genetics, EHR and BioBanks to Drive Precision Medicine |
19:20 | 19:25 | Closing Remarks by Dr. Younes Mokrab |
**TRACKS 3 & 4 WILL RUN IN CONCURRENT SESSIONS
Day 2: Sunday 5th December 2021 - TRACK 3 | |||
“PRECISION CARE IN MATERNAL AND CHILD HEALTH” | |||
14:00 | 14:10 | Welcome Note Dr. Souhaila Al Khodor Sidra Medicine, Qatar |
|
Session 1: Precision Medicine for Successful Pregnancy Outcomes | |||
Objectives:
|
|||
14:10 | 14:30 | Dr. Nady Elhajj Hamad Bin Khalifa University, Qatar |
“Male Obesity and Aging Effects on the Sperm Epigenome and Possible Consequences for the Next Generation” |
14:30 | 14:50 | Dr. Johnny Awwad Sidra Medicine, Qatar |
“Pre-implantation genetic testing for the selection of the best embryo: A critical appraisal and future directives. |
14:50 | 15:10 | Dr. Tawfeg Bin Omran Sidra Medicine, Qatar |
“Prenatal Genetic Counselling” |
15:10 | 15:40 | Keynote Speaker: Dr. Anna David University College London, UK |
“Precision Medicine in Utero” |
15:40 | 16:00 | Break | |
Session 2: Early Diagnosis and Treatment of Pregnancy Complications -Focus on Preterm Birth | |||
Objectives:
|
|||
16:00 | 16:20 | Dr. Nima Aghaeepour Stanford University, USA |
Machine Learning for Multiomics Analysis of the Immune System during Pregnancy |
16:20 | 16:40 | Dr. Rachel Tribe King’s College London, UK |
Preterm Birth Risk Prediction and the need for Clinically Useful Biomarkers to Predict PTB |
16:40 | 17:00 | Dr. Ramkumar Menon University of Texas Medical Branch, USA |
“Delivery of Anti-Inflammatory Drugs Using Extracellular Vesicles to Reduce the Risk of Preterm Birth” |
17:00 | 17:20 | Break | |
Session 3: Covid- 19 in Pregnancy and lessons learned from Big Data | |||
Objectives:
|
|||
17:20 | 17:40 | Dr. Valeria Savasi University of Milan, Italy |
SARS- COV 2 infection and pregnancy from the first trimester to the delivery |
17:40 | 18:00 | Dr. Albert Adu Opoka Hamad Medical Corporation-Al Wakra Hospital, Qatar |
COVID-19 in pregnancy- experience from Al Wakra Hospital, Qatar |
18:00 | 18:20 | Dr. Claudio Fenizia University of Milan, Italy |
Covid-19 and Pregnancy: is there a vertical transmission? |
18:20 | 18:50 | Keynote Speaker: Dr. Michael Snyder Stanford University, USA |
Big data and Health |
18:50 | 19:00 | Q&A | |
19:20 | 19:25 | Closing Remarks by Dr. Souhaila Al Khodor |
Day 2: Sunday 5th December 2021 - Track 4 | |||
“ADVANCES IN INNOVATIVE THERAPIES FOR PRECISION MEDICINE” | |||
14:00 | 14:10 | Welcome Note Dr. Cristina Maccalli Sidra Medicine, Qatar |
|
Session 1: The New Dimension of Clinical Care: Prospects and Challenges in Gene Therapy and Immune Related Disorder | |||
Objectives:
|
|||
14:10 | 14:40 | Keynote Speaker: Dr. Alessandro Aiuti San Raffaele Hospital Milan, Italy |
Hematopoietic stem cell gene therapy for inborn errors: turning blood (stem) cells into a medicine |
14:40 | 15:00 | Dr. Holm Uhlig University of Oxford, UK |
One gene has many phenotypes - understanding the complexity of IL6 cytokine family signaling through monogenic disorders |
15:00 | 15:20 | Dr. Mamoun Elawad Sidra Medicine, Qatar |
Precision medicine in VEO-IBD |
15:20 | 15:40 | Dr. Ronald Crystal WCU-NY, USA |
Gene Therapy for Neurodegeneration |
15:40 | 16:00 | Break | |
Session 2: The Promise of Precision Medicine: From Bench to the Bedside | |||
Objectives:
|
|||
16:00 | 16:20 | Dr. Massimo Gadina NIH-Bethesda MD, USA |
JAKPOT! JAK Inhibitors as a Therapeutic Strategy for Inflammatory and Rheumatic Diseases |
16:20 | 16:40 | Dr. Paolo Martini Moderna Therapeutics, USA |
mRNA Therapy for Inborn Error of Metabolism Disorders |
16:40 | 17:00 | Dr. Eliana Ruggiero San Raffaele Hospital Milan, Italy |
Gene Editing for Improving Safety and Efficacy of Cancer Adoptive Immunotherapy |
17:00 | 17:20 | Break | |
Session 3: Advances in Cancer Cell Therapy and Gene Editing: Paving the New Era in Patient Centric Care | |||
Objectives:
|
|||
17:20 | 17:50 | Keynote Speaker: Dr. Steven Rosenberg National Cancer Institute, USA |
Cell Therapy for Metastatic Cancer |
17:50 | 18:10 | Dr. Adrian Bot Kite Pharma, A Gilead Company, USA |
Approaches to Define and Overcome CAR T Cell Treatment Resistance |
18:10 | 18:30 | Dr. Stanley Qi Stanford University, USA |
Programmable Genome Engineering for High-Precision Gene Therapy |
18:30 | 18:50 | Dr. Francesco Marincola Kite Pharma, A Gilead Company, USA |
Next generation CAR therapies for Cancer Therapy: making it better rather than easier |
18:50 | 19:00 | Q&A | |
19:20 | 19:25 | Closing Remarks by Dr. Cristina Maccalli |
Day 3: Monday 6th December 2021 - Satellite Symposium | |||
“UNLOCKING THE FULL POTENTIAL OF PRECISION MEDICINE: OVERCOMING THE CHALLENGES AND THE GEOGRAPHICAL DISTRIBUTION OF ADVANCED THERAPIES” | |||
13:30 | 13:40 | Welcome Note Dr. Cristina Maccalli Sidra Medicine, Qatar |
|
Session 1: The state of the art in Qatar of the translational application of Precision Medicine | |||
Objectives:
|
|||
13:40 | 14:00 | Prof. Khaled Machaca WCM-Q, Qatar |
What are the opportunities for personalized medicine application in Qatar? |
14:00 | 14:20 | Dr. Khalid Ibrahim Sidra Medicine, Qatar |
Spinal Muscular Atrophy; The Search for a Cure |
14:20 | 14:40 | Dr. Kakil Ibrahim Rasul NCCCR/HMC, Qatar |
Personalizing mCRC Therapy with Novel Biomarker-Driven Treatments |
14:40 | 15:00 | Dr. Nahla Afifi Qatar Biobank Director, Qatar |
The impact of Qatar Biobank on Precision Medicine Initiative “Opportunities and Challenges” |
15:00 | 15:20 | Break | |
15:20 | 15:40 | Dr. Hadi Mohamad Abu Rasheed Qatar Cancer Society, Qatar |
How could the Cancer Civil Society Organizations play a catalyst role in Precision Medicine? |
15:40 | 15:50 | Introduction to the panel discussion | |
Panel Discussion: Advanced Therapies in Qatar: more to come |
|||
15:50 | 17:00 |
HE. Dr. Mohammed Bin Hamad Al-Thani Dr. Ayman Saleh Dr. Salha Bujassoum Dr. Dave Brown |
|
17:00 | 17:05 | Closing Remarks by Dr. Cristina Maccalli |
“This activity is an Accredited Group Learning Activity Category 1 as defined by the Ministry of Public Health’s Department of Healthcare Professions - Accreditation Section (DHP-AS) and is approved for a maximum of 12 hours.” “This activity was planned and for the healthcare team, and learners will receive 12 hours Interprofessional Continuing Education (IPCE) credits for learning and change” |